Rapport Therapeutics, Inc. SEC filings RAPP

Rapport Therapeutics, Inc. has 253 filings in SEC EDGAR's recent list, going back to Mar 27, 2024. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Rapport Therapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
4 Insider transaction Nov 3, 2026 Oct 30, 2026
4 Insider transaction Oct 30, 2026 Oct 28, 2026
8-K Current report
Material agreement, Results of operations, New debt, Unregistered share sale
Oct 30, 2026 Oct 28, 2026
424B5 Prospectus supplement Oct 30, 2026 —
424B5 Prospectus supplement Oct 30, 2026 —
305B2 Filing Oct 29, 2026 —
FWP Free writing prospectus Oct 28, 2026 —
FWP Free writing prospectus Oct 28, 2026 —
FWP Free writing prospectus Oct 28, 2026 —
FWP Free writing prospectus Oct 28, 2026 —
424B5 Prospectus supplement Oct 27, 2026 —
424B5 Prospectus supplement Oct 27, 2026 —
4 Insider transaction Oct 23, 2026 Oct 21, 2026
4 Insider transaction Oct 23, 2026 Oct 23, 2026
4 Insider transaction Oct 22, 2026 Oct 22, 2026
4 Insider transaction Oct 22, 2026 Oct 22, 2026
4 Insider transaction Oct 22, 2026 Oct 22, 2026
4 Insider transaction Oct 22, 2026 Oct 22, 2026
4 Insider transaction Oct 21, 2026 Oct 21, 2026
8-K Current report
Regulation FD disclosure, Other events
Oct 20, 2026 Oct 20, 2026
4 Insider transaction Oct 8, 2026 Oct 6, 2026
144 Notice of proposed sale Oct 6, 2026 —
4 Insider transaction Oct 1, 2026 Sep 30, 2026
144 Notice of proposed sale Sep 30, 2026 —
4 Insider transaction Sep 24, 2026 Sep 23, 2026
4 Insider transaction Sep 9, 2026 Sep 8, 2026
4 Insider transaction Aug 26, 2026 Aug 25, 2026
4 Insider transaction Aug 26, 2026 Aug 24, 2026
144 Notice of proposed sale Aug 25, 2026 —
144 Notice of proposed sale Aug 24, 2026 —
4 Insider transaction Aug 20, 2026 Aug 19, 2026
144 Notice of proposed sale Aug 19, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 12, 2026 Aug 10, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 5, 2026 Aug 5, 2026
4 Insider transaction Jul 29, 2026 Jul 27, 2026
4 Insider transaction Jul 15, 2026 Jul 14, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 29, 2026
144 Notice of proposed sale Jun 30, 2026 —
144 Notice of proposed sale Jun 29, 2026 —
4 Insider transaction Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 10, 2026 Jun 10, 2026
4 Insider transaction Jun 10, 2026 Jun 10, 2026
8-K Current report
Shareholder vote results
Jun 10, 2026 Jun 10, 2026
4 Insider transaction May 28, 2026 May 26, 2026
144 Notice of proposed sale May 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
4 Insider transaction May 13, 2026 May 11, 2026
4 Insider transaction May 11, 2026 May 7, 2026
144 Notice of proposed sale May 11, 2026 —
144 Notice of proposed sale May 8, 2026 —
144 Notice of proposed sale May 7, 2026 —
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 23, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 23, 2026 —
DEF 14A Proxy statement Apr 23, 2026 Jun 10, 2026
4 Insider transaction Apr 21, 2026 Apr 17, 2026
4 Insider transaction Apr 21, 2026 Apr 17, 2026
8-K Current report
Regulation FD disclosure, Other events
Apr 21, 2026 Apr 21, 2026
144 Notice of proposed sale Apr 17, 2026 —
144 Notice of proposed sale Apr 17, 2026 —
4 Insider transaction Apr 14, 2026 Apr 10, 2026
144 Notice of proposed sale Apr 13, 2026 —
144 Notice of proposed sale Apr 10, 2026 —
4 Insider transaction Apr 9, 2026 Apr 8, 2026
144 Notice of proposed sale Apr 8, 2026 —
4 Insider transaction Mar 31, 2026 Mar 30, 2026
144 Notice of proposed sale Mar 30, 2026 —
4 Insider transaction Mar 26, 2026 Mar 25, 2026
144 Notice of proposed sale Mar 25, 2026 —
S-3ASR Automatic shelf registration Mar 10, 2026 —
S-8 Employee stock plan registration Mar 10, 2026 —
10-K Annual report Mar 10, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 10, 2026 Mar 10, 2026
4 Insider transaction Mar 9, 2026 Mar 5, 2026
144 Notice of proposed sale Mar 5, 2026 —
4 Insider transaction Feb 19, 2026 Feb 18, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Jan 22, 2026 Jan 20, 2026
SCHEDULE 13G Ownership over 5% (passive) Jan 21, 2026 —
4 Insider transaction Jan 16, 2026 Jan 15, 2026
144 Notice of proposed sale Jan 15, 2026 —
8-K Current report
Other events
Jan 7, 2026 Jan 7, 2026
424B5 Prospectus supplement Jan 7, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jan 7, 2026 Jan 7, 2026
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
4 Insider transaction Dec 18, 2025 Dec 17, 2025
144 Notice of proposed sale Dec 17, 2025 —
144 Notice of proposed sale Dec 17, 2025 —
4 Insider transaction Dec 16, 2025 Dec 15, 2025
4 Insider transaction Dec 1, 2025 Nov 26, 2025
4 Insider transaction Nov 18, 2025 Nov 17, 2025
4 Insider transaction Nov 18, 2025 Nov 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 22, 2025 —
4 Insider transaction Oct 16, 2025 Oct 15, 2025
4 Insider transaction Oct 16, 2025 Oct 15, 2025
144 Notice of proposed sale Oct 15, 2025 —
4 Insider transaction Sep 19, 2025 Sep 17, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 18, 2025 —
144 Notice of proposed sale Sep 17, 2025 —
144 Notice of proposed sale Sep 17, 2025 —
4 Insider transaction Sep 17, 2025 Sep 15, 2025
4 Insider transaction Sep 15, 2025 Sep 12, 2025
4 Insider transaction Sep 15, 2025 Sep 12, 2025
4 Insider transaction Sep 11, 2025 Sep 11, 2025
8-K Current report
Material agreement
Sep 10, 2025 Sep 9, 2025
424B5 Prospectus supplement Sep 10, 2025 —
4 Insider transaction Sep 10, 2025 Sep 8, 2025
424B5 Prospectus supplement Sep 8, 2025 —
144 Notice of proposed sale Sep 8, 2025 —
8-K Current report
Other events
Sep 8, 2025 Sep 8, 2025
8-K Current report
Regulation FD disclosure, Other events
Sep 8, 2025 Sep 8, 2025
4 Insider transaction Aug 18, 2025 Aug 15, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 7, 2025 Aug 7, 2025
4 Insider transaction Jul 16, 2025 Jul 15, 2025
EFFECT Filing Jul 9, 2025 —
EFFECT Filing Jul 9, 2025 —
CORRESP Letter to the SEC Jul 7, 2025 —
CORRESP Letter to the SEC Jul 7, 2025 —
UPLOAD Letter from the SEC Jul 7, 2025 —
UPLOAD Letter from the SEC Jul 7, 2025 —
S-3 Shelf registration Jul 1, 2025 —
S-3 Shelf registration Jul 1, 2025 —
8-K Current report
Shareholder vote results
Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
4 Insider transaction Jun 18, 2025 Jun 16, 2025
4 Insider transaction Jun 18, 2025 Jun 17, 2025
144 Notice of proposed sale Jun 16, 2025 —
8-K Current report
Regulation FD disclosure, Other events
Jun 2, 2025 Jun 2, 2025
4 Insider transaction May 19, 2025 May 15, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
ARS Annual report to shareholders Apr 24, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 17, 2025
4 Insider transaction Apr 16, 2025 Apr 15, 2025
4 Insider transaction Apr 3, 2025 Apr 1, 2025
4 Insider transaction Mar 17, 2025 Mar 14, 2025
144 Notice of proposed sale Mar 14, 2025 —
4 Insider transaction Mar 13, 2025 Mar 12, 2025
4 Insider transaction Mar 13, 2025 Mar 12, 2025
S-8 Employee stock plan registration Mar 11, 2025 —
10-K Annual report Mar 11, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 11, 2025 Mar 11, 2025
4 Insider transaction Mar 5, 2025 Mar 3, 2025
3 Initial insider ownership Mar 5, 2025 Mar 3, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 3, 2025 Mar 3, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 13, 2025 —
4 Insider transaction Feb 4, 2025 Feb 3, 2025
4 Insider transaction Feb 4, 2025 Feb 3, 2025
4 Insider transaction Feb 4, 2025 Feb 3, 2025
4 Insider transaction Feb 4, 2025 Feb 3, 2025
4 Insider transaction Feb 4, 2025 Feb 3, 2025
8-K Current report
Regulation FD disclosure, Other events
Jan 10, 2025 Jan 9, 2025
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
4 Insider transaction Nov 7, 2024 Nov 7, 2024
4 Insider transaction Nov 7, 2024 Nov 7, 2024
4 Insider transaction Nov 7, 2024 Nov 7, 2024
4 Insider transaction Nov 7, 2024 Nov 7, 2024
3 Initial insider ownership Nov 7, 2024 Nov 7, 2024
3 Initial insider ownership Nov 7, 2024 Nov 7, 2024
3 Initial insider ownership Nov 7, 2024 Nov 7, 2024
3 Initial insider ownership Nov 7, 2024 Nov 7, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RAPP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
2012593
Former names
Rapport Therapeutics, Inc. (until Nov 4, 2026)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.